<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:04:51Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/33366" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/33366</identifier><datestamp>2026-07-18T07:06:46Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Didar, Tohid</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Alfadhli, Abeer</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Biomedical Engineering</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-07-17T19:14:29Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2026</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/11375/33366</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/405</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Cardiovascular device infections remain difficult to manage because bacteria rapidly adhere to biomaterial surfaces and mature into biofilms that resist antimicrobial therapy. This thesis investigates bacteriophage-based strategies for cardiovascular device infection control, with emphasis on bacteriophage-functionalized expanded polytetrafluoroethylene (ePTFE) vascular grafts. Chapter 1 introduces the clinical problem, rationale, research objective, and thesis organization. Chapter 2 reviews the biological basis of bacteriophage therapy, biofilm disruption, phage-antibiotic interactions, resistance, immune considerations, cardiovascular device applications, and regulatory issues for phage-functionalized devices. Chapter 3 describes the materials and methods used for ePTFE surface functionalization, phage preparation, surface characterization, biofilm assays, crystal violet staining, XTT metabolic activity testing, microscopy, microfluidic washing, bovine serum exposure, and plasma-contacting assays. Chapter 4 presents the experimental results. Surface characterization showed route-dependent ePTFE modification, while biological testing showed that durable retention of infectious phage was the main determinant of antimicrobial performance. GPTMS phage grafts produced the strongest retention-linked biofilm suppression, retained infectious phage after sustained microfluidic washing, preserved visible antibacterial activity after bovine serum exposure, and did not increase peak thrombin relative to untreated ePTFE in initial plasma-contacting screening. Chapter 5 integrates these findings and identifies the main translational needs, including broader pathogen testing, phage cocktail development, human blood-contacting validation, endothelialization assessment, dry-storage testing, sterilization compatibility, and larger vascular-flow models. Together, these findings support GPTMS-mediated bacteriophage immobilization as a proof-of-concept antimicrobial coating strategy for ePTFE vascular grafts while defining the next studies required before clinical translation.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree">Master of Applied Science (MASc)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="rights" lang="en">Attribution-NonCommercial-NoDerivs 2.5 Canada</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri">http://creativecommons.org/licenses/by-nc-nd/2.5/ca/</dim:field>
   <dim:field mdschema="dc" element="subject">Bacteriophage</dim:field>
   <dim:field mdschema="dc" element="subject">vascular graft</dim:field>
   <dim:field mdschema="dc" element="subject">ePTFE</dim:field>
   <dim:field mdschema="dc" element="subject">MEDICINE::Dermatology and venerology,clinical genetics, internal medicine::Internal medicine::Cardiovascular medicine</dim:field>
   <dim:field mdschema="dc" element="subject">expanded polytetrafluoroethylene</dim:field>
   <dim:field mdschema="dc" element="title">Bacteriophage-Functionalized Expanded Polytetrafluoroethylene Vascular Grafts for Biofilm Control</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative">Bacteriophage Therapy in Cardiovascular Medicine: A Paradigm Shift in the Prevention of Device-Related Infections</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative">GPTMS-Mediated Bacteriophage Functionalization of ePTFE Vascular Grafts Improves Durable Phage Retention and Suppresses Staphylococcus aureus Biofilm Formation</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>